Compounds > haloperidol

haloperidol and istradefylline

haloperidol has been researched along with istradefylline in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Bertorelli, R; Costentin, J; El Yacoubi, M; Ledent, C; Ongini, E; Parmentier, M; Vaugeois, JM1
Costentin, J; El Yacoubi, M; Vaugeois, JM1
Fisone, G; Galdi, S; Greengard, P; Håkansson, K; Hendrick, J; Snyder, G1
Grzelak, ME; Hodgson, RA; Hunter, JC; Parker, EM; Pond, AJ; Varty, GB1
Bertran-Gonzalez, J; Borgkvist, A; Brami-Cherrier, K; Fisone, G; Girault, JA; Greengard, P; Håkansson, K; Hervé, D; Irinopoulou, T; Usiello, A; Valjent, E1
Collins, LE; Farrar, AM; Font, L; Nunes, EJ; Patel, V; Sager, TN; Salamone, JD; Schlar, DE1
Bertran-Gonzalez, J; Bonito-Oliva, A; Fisone, G; Girault, JA; Pallottino, S; Valjent, E1
Correa, M; Ecevitoglu, A; Edelstein, GA; Lindgren, H; Mombereau, C; Moore, A; Nicholas, C; Presby, RE; Rotolo, RA; Salamone, JD1

Other Studies

8 other study(ies) available for haloperidol and istradefylline

ArticleYear
Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice.
    British journal of pharmacology, 2001, Volume: 134, Issue:1

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Blepharoptosis; Disease Models, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Immobilization; Male; Mice; Mice, Knockout; Motor Activity; Purinergic P1 Receptor Antagonists; Purines; Pyrimidines; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; Reserpine; Swimming; Time Factors; Triazoles

2001
Adenosine A2A receptors and depression.
    Neurology, 2003, Dec-09, Volume: 61, Issue:11 Suppl 6

    Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Depression; Disease Models, Animal; Dopamine Antagonists; Drug Interactions; Haloperidol; Mice; Mice, Knockout; Motor Activity; Neurotransmitter Agents; Parkinsonian Disorders; Purines; Pyrimidines; Receptor, Adenosine A2A; Triazines; Triazoles

2003
Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors.
    Journal of neurochemistry, 2006, Volume: 96, Issue:2

    Topics: Adenosine A2 Receptor Antagonists; Amino Acid Sequence; Animals; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Haloperidol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Purines; Quinpirole; Receptors, AMPA; Receptors, Dopamine D2; Serine; Threonine

2006
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
    Psychopharmacology, 2008, Volume: 200, Issue:3

    Topics: Adenosine A2 Receptor Antagonists; Animals; Antipsychotic Agents; Caffeine; Catalepsy; Cebus; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Globus Pallidus; Haloperidol; Neurologic Examination; Purines; Pyrimidines; Receptor, Adenosine A2A; Saimiri; Triazoles; Xanthines

2008
Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:7

    Topics: Acetylation; Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Gene Expression Regulation, Enzymologic; Green Fluorescent Proteins; GTP-Binding Protein alpha Subunits; Haloperidol; Histones; Male; Mice; Mice, Transgenic; Neurons; Phosphorylation; Purines; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Ribosomal Protein S6 Kinases, 90-kDa; Threonine

2009
Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.
    Behavioural brain research, 2009, Jul-19, Volume: 201, Issue:1

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Behavior, Animal; Caffeine; Central Nervous System Agents; Choice Behavior; Conditioning, Operant; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Feeding Behavior; Haloperidol; Male; Motivation; Purines; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Xanthines

2009
Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1.
    Neuropharmacology, 2013, Volume: 72

    Topics: Adenosine A2 Receptor Antagonists; Aminoacetonitrile; Animals; Clozapine; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; GABA Antagonists; Gene Expression Regulation; Haloperidol; In Vitro Techniques; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multiprotein Complexes; Mutation; Phosphorylation; Protease Inhibitors; Protein Phosphatase 1; Purines; Ribosomal Protein S6; Signal Transduction; TOR Serine-Threonine Kinases

2013
Effort-related effects of chronic administration of the DA D
    Psychopharmacology, 2023, Volume: 240, Issue:10

    Topics: Adenosine; Animals; Antipsychotic Agents; Haloperidol; Purines; Rats

2023